Smith C - Search Results

1

The molecular genetics of medulloblastoma: an assessment of new therapeutic targets.

Carlotti CG Jr, Smith C, Rutka JT. Carlotti CG Jr, et al. Among authors: smith c. Neurosurg Rev. 2008 Oct;31(4):359-68; discussion 368-9. doi: 10.1007/s10143-008-0146-4. Epub 2008 Jun 12. Neurosurg Rev. 2008. PMID: 18548301 Review.

2

An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.

Kongkham PN, Northcott PA, Ra YS, Nakahara Y, Mainprize TG, Croul SE, Smith CA, Taylor MD, Rutka JT. Kongkham PN, et al. Cancer Res. 2008 Dec 1;68(23):9945-53. doi: 10.1158/0008-5472.CAN-08-2169. Cancer Res. 2008. PMID: 19047176

3

The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells.

Osawa H, Smith CA, Ra YS, Kongkham P, Rutka JT. Osawa H, et al. Neuro Oncol. 2009 Aug;11(4):381-93. doi: 10.1215/15228517-2008-110. Epub 2008 Dec 16. Neuro Oncol. 2009. PMID: 19088174 Free PMC article.

4

The evolution and application of techniques in molecular biology to human brain tumors: a 25 year perspective.

Rutka JT, Kongkham P, Northcott P, Carlotti C, Guduk M, Osawa H, Moreno O, Seol HJ, Restrepo A, Weeks A, Nagai S, Smith C. Rutka JT, et al. Among authors: smith c. J Neurooncol. 2009 May;92(3):261-73. doi: 10.1007/s11060-009-9829-0. Epub 2009 Apr 9. J Neurooncol. 2009. PMID: 19357954 Review.

5

Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.

Nakahara Y, Northcott PA, Li M, Kongkham PN, Smith C, Yan H, Croul S, Ra YS, Eberhart C, Huang A, Bigner D, Grajkowska W, Van Meter T, Rutka JT, Taylor MD. Nakahara Y, et al. Among authors: smith c. Neoplasia. 2010 Jan;12(1):20-7. doi: 10.1593/neo.91122. Neoplasia. 2010. PMID: 20072650 Free PMC article.

6

The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma.

Kongkham PN, Northcott PA, Croul SE, Smith CA, Taylor MD, Rutka JT. Kongkham PN, et al. Among authors: smith ca. Oncogene. 2010 May 20;29(20):3017-24. doi: 10.1038/onc.2010.32. Epub 2010 Mar 8. Oncogene. 2010. PMID: 20208569

7

Genetics of medulloblastoma: clues for novel therapies.

Onvani S, Etame AB, Smith CA, Rutka JT. Onvani S, et al. Expert Rev Neurother. 2010 May;10(5):811-23. doi: 10.1586/ern.10.31. Expert Rev Neurother. 2010. PMID: 20420498 Review.

8

Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in Medulloblastoma.

Kongkham PN, Onvani S, Smith CA, Rutka JT. Kongkham PN, et al. Transl Oncol. 2010 Dec 1;3(6):336-43. doi: 10.1593/tlo.10121. Transl Oncol. 2010. PMID: 21151472 Free PMC article.

9

Epigenetic mechanisms regulating neural development and pediatric brain tumor formation.

Faria CM, Rutka JT, Smith C, Kongkham P. Faria CM, et al. Among authors: smith c. J Neurosurg Pediatr. 2011 Aug;8(2):119-32. doi: 10.3171/2011.5.PEDS1140. J Neurosurg Pediatr. 2011. PMID: 21806352 Review.

10

Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology.

Etame AB, Diaz RJ, Smith CA, Mainprize TG, Hynynen K, Rutka JT. Etame AB, et al. Neurosurg Focus. 2012 Jan;32(1):E3. doi: 10.3171/2011.10.FOCUS11252. Neurosurg Focus. 2012. PMID: 22208896 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results